fusion. Relative to the control side, dipyridamole caused a twofold increase in basal dialysate adenosine concen tration and increased dialysate adenosine concentration at 10 and 15 min of reperfusion, but no increase in dialy sate adenosine occurred during and immediately after ischemia. The results indicate that, in the piglet brain, cerebral ischemia markedly elevates intracerebral extra cellular adenosine concentration and that dipyridamole increases extracellular adenosine levels. Key Words: Ad enosine-Brain dialysis-Dipyridamole-Ischemia. demonstrated inhibition of cellular uptake of ade nosine by dipyridamole (Mustafa et al. , 1975; Hertz, 1978; Thampy and Barnes, 1983) , direct ev idence is currently lacking regarding the effect of dipyridamole on extracellular adenosine in vivo.
For the present study, we utilized the brain dialysis technique, which allows infusion of substances lo cally into the brain surrounding the dialysis probe while extracellular adenosine in the same region is simultaneously sampled (Park et ai. , 1988; Van Wylen et aI. , 1988) . In particular, dipyridamole was infused into the cerebral cortex and extracellular adenosine was sampled under control conditions, during cerebral ischemia, and during the subse quent reperfusion period.
METHODS

Animal preparations
Piglets «5 days of age) were anesthetized with ket amine (25 mg/kg i.m.) and xylazine (3 mg/kg i.m.), tra cheotomized, paralyzed (pancuronium bromide 1 mg/kg i.m.), and mechanically ventilated with a gas mixture of room air, O2, and 0.25-0.5% isoflurane. The inspired O2 and end-tidal CO2 were constantly monitored. The fem oral arteries were cannulated to record blood pressure and to draw blood samples for arterial blood gas analysis (Corning 158 pHlblood gas analyzer). The femoral vein was cannulated for infusion of fluids. EEG was recorded (Gould Brush 260) from stainless-steel scalp electrodes. The chest was opened through the left second intercostal space, and a ligature was then placed around the subcla vian and brachiocephalic arteries at their junction with the aorta. Rectal temperature was maintained at 39 ± OSC with a heating pad. At the end of the experiments, the animals were killed by intravenous infusion of satu rated KCl.
Brain dialysis
The brain dialysis technique used has been detailed previously (Van Wylen et aI., 1986; Park et aI., 1987) . Briefly, two dialysis probes were implanted bilaterally in the frontal cortex. After implantation of the probe, 1.5 h was allowed to achieve the steady-state purine levels (Park et aI., 1987) . Artificial CSF was infused after the 1.5-h waiting period through the probe at a flow rate of 2 fLlImin throughout the rest of the experiments (Carnegie Medicine AB model CMA/100). Artificial CSF consisted of (mM) NaCI 132.8, KCl 3.0, CaCl2 2.0, MgCl2 0.7, NaHC03 24.6, urea 6.7, and glucose 3.7. The CSF was bubbled with 95% N2/5% CO2 to achieve a pH of 7.2 and P02 of 25-39 mm Hg. The dialysate samples were col lected into preweighed vials, weighed to determine the dialysate volume collected, and stored in a freezer prior to analysis.
Experimental protocol
Group 1 (n = 8)
In this group, the perfusate used was artificial CSF alone without dipyridamole or methanol. Although each animal had the probes on each side, dialysate adenosine concentrations were measured from samples collected on one side only. First, a control dialysate sample was col lected for 5 min. Then, while dialysate was continuously collected, a 5-min period of global cerebral ischemia was induced by closing the ligature placed around the brachio cephalic and subclavian arteries. After the period of ce rebral ischemia, cerebral circulation was rapidly restored by releasing the ligature. During the next 15 min following the ischemia, a dialysate sample was collected every 5 min.
Group 2A and 2B (n = 10)
In group 2, the probe on the left side was perfused with artificial CSF containing 1 % methanol (designated as group 2A); the probe on the right side was perfused with artificial CSF containing 10 -4 M dipyridamole in 1 % methanol (designated as group 2B). The 1% methanol re sulted from dilution of a stock solution of 10-2 M dipy ridamole (Boehringer Ingelheim, Ridgefield, CT, U.S.A.) in 100% methanol to 10 -4 M with artificial CSF. After the 1.5-h waiting period without perfusion had elapsed, the probes were perfused at 2 fLlImin for 0.5 h to allow dipy ridamole and methanol to diffuse into the tissue surround ing the probe prior to collection of dialysate samples. Dialysate samples were collected following the same pro tocol as that for group 1.
Sample processing and analysis
The dialysate samples were diluted with distilled water to a total volume of 120 fLl, and 100 fLl of the diluted samples was analyzed for adenosine, inosine, and hypo-xanthine by reversed-phase HPLC. The samples were as sayed with a linear gradient method [methanol 0% (pH 4.5) to 25% (pH 5.3) in 100 roM KH2P0 4 and a flow rate of 1 mllmin] (Park et aI., 1988) . Identification and quan tification of adenosine, inosine, and hypoxanthine were made by comparison of retention times and peak heights with those of known standards.
Statistical analysis
A two-way analysis of variance was used to test for significant differences among means in the same group, and a paired t test with a Bonferroni correction was used to test which means were different. A nonpaired t test with a Bonferroni correction was used to test for differ ences among means of groups 1 and 2A. A P value of <0.05 was considered significant. All values are given as means ± SE.
RESULTS
During cerebral ischemia, MABP rose markedly (control 77 ± 3 mm Hg, ischemia 127 ± 9 mm Hg in group 1; control 72 ± 2 mm Hg, ischemia 123 ± 4 mm Hg in group 2). Within 2 min after the ischemia, the blood pressure returned to control levels. Arte 
DISCUSSION
We have demonstrated in piglets that dipyrid amole and cerebral ischemia increase brain paren chymal extracellular adenosine levels in vivo. This is the first study to utilize the brain dialysis probe to infuse dipyridamole into a discrete area of brain tis sue. We do not have data regarding the concentra tion of dipyridamole achieved in the extracellular space surrounding the dialysis probe. However, our finding that 10-4 M dipyridamole in the dialysis per fusate was necessary to obtain increases in basal adenosine levels, whereas increases in extracellular adenosine have been demonstrated with 10-5 M in cultured heart cells (Meghji et aI., 1985; Mustafa et aI., 1975) and astrocytes (Hertz, 1978) , suggests that the drug does not completely equilibrate with the tissue at the perfusion flow rate we utilized. On the other hand, local infusion of dipyridamole cir cumvents the potential pharmacokinetic problems associated with parenteral administration of the drug. Using the latter approach, Phillis et ai. (1989) J Cereb Blood Flow Metab, Vol. 10, No.3, 1990 found no effect of intravenous dipyridamole on the amount of adenosine accumulating in a cerebral cortical cup; however, the potentiation of the in crease in cup adenosine occurring during recovery from severe hypoxia/ischemia in the study indicates some passage of the drug across the blood-brain barrier.
We observed that basal dialysate adenosine lev els almost doubled in the presence of dipyridamole.
Such an increase would be expected in a tissue wherein minimal washout of extracellular adeno sine into the venous blood occurs due to the imper meable nature of the blood-brain barrier to adeno sine (Berne et aI., 1974; Winn et aI., 1980) and rapid uptake of adenosine by neurons and glia (Hertz, 1978; Thampy and Barnes, 1983) . This increase is also consistent with previous reports of an aug mented CBF response to dipyridamole. Heistad et ai. (1981) and Puiroud et ai. (1988) observed in creases in resting CBF of rabbits in response to intracarotid and intravenous administration of dipy ridamole. The enhanced CBF response was also re ported to occur during hypoxia following intrave nous administration of dipyridamole (Phillis et aI., 1984) . Similarly, Ngai et ai. (1985) We expect that the lack of an effect of dipyrid amole on extracellular adenosine level during and immediately after cerebral ischemia occurs because adenosine formation and release are maximized af ter 5 min of ischemia, and the continued inhibition of adenosine uptake under conditions that promote maximal release would not increase extracellular adenosine further. It is also possible that the extent of uptake inhibition by dipyridamole is reduced in the presence of increased extracellular adenosine, as observed in cell cultures by Pearson et ai. (1978) .
The elevated extracellular adenosine levels mea sured later in the reperfusion period, when adeno sine release is no longer maximized, simply reflect the continued inhibition of adenosine uptake by this drug.
Increases in adenosine with decreases in O2 sup ply are predicted by the adenosine hypothesis for the regulation of CBF (Berne et aI., 1974; Winn et aI., 1981) . The 5.7-fold increase in dialysate adeno sine (group 2A) that we observed in the frontal cor-tex in response to cerebral ischemia supports this hypothesis, as does the 2. 5-fold increase in extra cellular adenosine measured in the thalamus of pig lets during 10 min of severe hypoxia (Park et aI., 1987) . Thirtyfold (Van Wylen et aI. , 1986) and 16fold (Hagberg et al. 1987 ) increases in adenosine levels have also been measured by brain dialysis in the rat striatum during 10 and 15 min of cerebral ischemia, respectively.
In conclusion, local infusion of dipyridamole into the frontal cortex of piglets via the brain dialysis probe caused increases in cerebral extracellular ad enosine under basal conditions and also following cerebral ischemia, indicative of inhibition of paren chymal extracellular adenosine uptake by dipyrid amole in this animal model. Intracerebral extracel lular adenosine levels also increased in response to cerebral ischemia. These data suggest a role for ad enosine in the regulation of CBF in the neonate.
